-
Stimulus bill packs a windfall for FDA and COVID-19 drug developers — Roche nixes Tecentriq bladder cancer accelerated approval — AI uncovers Lilly's Olumiant as potential Alzheimer's treatment See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new pageDismiss Notice
Abbott gets 6 Month Lupron Approval
Discussion in 'Watson' started by Anonymous, Mar 13, 2010 at 12:33 PM.
Tags:
Add Tags
Page 1 of 3
Page 1 of 3